Analytical Data
-
基因名
Porcine circovirus 2 Capsid
-
简介
The porcine circovirus 2 capsid protein autonomously constructs the icosahedral capsid of the viral particle, which is essential for initial attachment to host cell surface proteoglycans.Small size contributes to environmental stability and disinfectant resistance.Porcine circovirus 2 Capsid protein (sf9, His) is the recombinant Virus-derived Porcine circovirus 2 Capsid protein, expressed by Sf9 insect cells , with C-His labeled tag.
- Application
-
别名
Capsid protein; Cap; ORF2
-
种属
Virus
-
表达系统
Baculovirus
-
标签
C-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O56129
-
表达区间
N42-P233
-
蛋白长度
Partial
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Porcine circovirus type 2 (PCV2) is a small, non-enveloped virus that belongs to the Circoviridae family and is primarily associated with various porcine diseases, including post-weaning multisystemic wasting syndrome (PMWS). The PCV2 capsid protein plays a crucial role in viral assembly, immunogenicity, and serotype determination, making it a key target for vaccine development and therapeutic interventions. Research into recombinant PCV2 capsid proteins has gained momentum due to the urgent need for effective vaccines to combat the economic losses caused by PCV2 infections in the swine industry. The use of recombinant DNA technology allows for the expression of the capsid protein in various host systems, facilitating the production of vaccines that can elicit protective immune responses in pigs. Moreover, studies have shown that the capsid protein can serve as an effective antigen for serological assays, enabling the monitoring of PCV2 circulation in livestock populations. Understanding the structure and function of the PCV2 capsid protein is essential for developing targeted strategies to control the virus and improve animal health. Consequently, ongoing research focuses on optimizing production methods, characterizing immune responses, and evaluating the efficacy of capsid-based vaccines in field trials. This research is critical not only for enhancing biosecurity in pig farming but also for reducing the reliance on antibiotics, addressing broader concerns related to animal welfare and public health.
